Solid Biosciences (SLDB) Other Non-Current Assets (2017 - 2026)

Solid Biosciences has reported Other Non-Current Assets for 10 years, with the latest figure at $708000.0 in Q1 2026.

• Quarterly Other Non-Current Assets fell 64.12% year-over-year to $708000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $708000.0 (down 64.12% YoY) and the FY2025 annual result came in at $768000.0, down 60.66% from the prior year.
• Other Non-Current Assets retreated to $708000.0 in Q1 2026 per SLDB's latest filing, from $768000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $2.1 million in Q1 2022 and troughed at $175000.0 in Q4 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets tumbled 91.55% in 2022, then surged 947.43% in 2023.
• Over 5 years, Other Non-Current Assets stood at $175000.0 in 2022, then soared by 947.43% to $1.8 million in 2023, then increased by 6.49% to $2.0 million in 2024, then slumped by 60.66% to $768000.0 in 2025, then slipped by 7.81% to $708000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $708000.0, $768000.0, and $247000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.